{"id":"https://openalex.org/W2564500684","doi":"https://doi.org/10.1182/blood.v116.21.3499.3499","title":"Maximally Tolerated Busulfan Area Under the Concentration-Time Curve (AUC) In Combination with Fludarabine as Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation.","display_name":"Maximally Tolerated Busulfan Area Under the Concentration-Time Curve (AUC) In Combination with Fludarabine as Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation.","publication_year":2010,"publication_date":"2010-11-19","ids":{"openalex":"https://openalex.org/W2564500684","doi":"https://doi.org/10.1182/blood.v116.21.3499.3499","mag":"2564500684"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v116.21.3499.3499","doi":"https://doi.org/10.1182/blood.v116.21.3499.3499","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.3499.3499","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079158736","display_name":"Janelle B. Perkins","orcid":"https://orcid.org/0000-0002-5681-9061","observed_orcids":["https://orcid.org/0000-0002-5681-9061"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Janelle Perkins","raw_affiliation_strings":["Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083349008","display_name":"Teresa L. Field","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Teresa Field","raw_affiliation_strings":["Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009314752","display_name":"Jongphil Kim","orcid":"https://orcid.org/0000-0002-7430-2226","observed_orcids":["https://orcid.org/0000-0002-7430-2226"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jongphil Kim","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012866839","display_name":"Hugo Francisco Fernandez","orcid":"https://orcid.org/0000-0002-7322-0392","observed_orcids":["https://orcid.org/0000-0002-7322-0392"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hugo F. Fernandez","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108298475","display_name":"Lia Elena Perez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lia Perez","raw_affiliation_strings":["Blood & Marrow Transplantation, H. Lee Moffitt Cancer Ctr., Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood & Marrow Transplantation, H. Lee Moffitt Cancer Ctr., Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004386819","display_name":"Ernesto Ayala","orcid":"https://orcid.org/0000-0002-4747-329X","observed_orcids":["https://orcid.org/0000-0002-4747-329X"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ernesto Ayala","raw_affiliation_strings":["BMT, H. Lee Moffitt Cancer Center, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BMT, H. Lee Moffitt Cancer Center, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017327825","display_name":"Mohamed A. Kharfan\u2010Dabaja","orcid":"https://orcid.org/0000-0001-7394-5185","observed_orcids":["https://orcid.org/0000-0001-7394-5185"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mohamed Kharfan-Dabaja","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009308127","display_name":"Marcie Tomblyn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcie Tomblyn","raw_affiliation_strings":["Dept. of Blood & Marrow Transplantation, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Blood & Marrow Transplantation, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102841436","display_name":"Daniel M. Sullivan","orcid":"https://orcid.org/0009-0003-0951-9781","observed_orcids":["https://orcid.org/0009-0003-0951-9781","https://orcid.org/0000-0002-2183-1773"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Sullivan","raw_affiliation_strings":["Clinical Investigations and Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center, Tampa, FL, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Investigations and Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center, Tampa, FL, USA,","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060783496","display_name":"Claudio Anasetti","orcid":"https://orcid.org/0000-0002-0119-0622","observed_orcids":["https://orcid.org/0000-0002-0119-0622"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Claudio Anasetti","raw_affiliation_strings":["H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5009314752","https://openalex.org/A5017327825","https://openalex.org/A5079158736"],"corresponding_institution_ids":["https://openalex.org/I3019308854"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.1997,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.64272899,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"116","issue":"21","first_page":"3499","last_page":"3499"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/busulfan","display_name":"busulfan","score":0.9309999942779541},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.9070000052452087},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9319999814033508},{"id":"https://openalex.org/keywords/conditioning-regimen","display_name":"conditioning regimen","score":0.8539999723434448},{"id":"https://openalex.org/keywords/area-under-the-concentration-time-curve","display_name":"area under the concentration-time curve","score":0.9369999766349792},{"id":"https://openalex.org/keywords/pharmacokinetic-modeling","display_name":"pharmacokinetic modeling","score":0.6209999918937683},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.4880000054836273},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.5860000252723694},{"id":"https://openalex.org/keywords/graft-versus-host-disease-prophylaxis","display_name":"graft-versus-host disease prophylaxis","score":0.7799999713897705},{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":0.9679999947547913},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9369999766349792},{"id":"https://openalex.org/keywords/mycophenolate-mofetil","display_name":"mycophenolate mofetil","score":0.9850000143051147},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8265848159790039},{"id":"https://openalex.org/C2780611847","wikidata":"https://www.wikidata.org/wiki/Q348922","display_name":"Busulfan","level":4,"score":0.77336585521698},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6847580671310425},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.6514652967453003},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.6219625473022461},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5788388252258301},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5718943476676941},{"id":"https://openalex.org/C2993713153","wikidata":"https://www.wikidata.org/wiki/Q211709","display_name":"Hematopoietic cell","level":4,"score":0.48161810636520386},{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.47760459780693054},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4060574173927307},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.40416407585144043},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3421904146671295},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.33339810371398926},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.29737532138824463},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2723139822483063},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.12366840243339539},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v116.21.3499.3499","doi":"https://doi.org/10.1182/blood.v116.21.3499.3499","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v116.21.3499.3499","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2066398683","https://openalex.org/W2588528479","https://openalex.org/W2559892488","https://openalex.org/W4389243936","https://openalex.org/W4310643630","https://openalex.org/W2519236218","https://openalex.org/W2552831806","https://openalex.org/W1992556058","https://openalex.org/W2096156027","https://openalex.org/W2590512007"],"abstract_inverted_index":{"Abstract":[0,1],"3499":[2],"Intravenous":[3],"busulfan":[4,592],"(IV":[5],"Bu)":[6],"dosing":[7],"in":[8,63,80,197,241,409,435,463,508,555,595,607],"hematopoietic":[9,604],"cell":[10,605],"transplantation":[11,606],"(HCT)":[12],"conditioning":[13,600],"regimens":[14],"has":[15,33],"been":[16,34,323],"based":[17,165,188,566],"largely":[18],"on":[19,149,156,166,189,213,300,327,480,567],"bioequivalence":[20],"studies":[21],"done":[22,223],"with":[23,65,87,210,283,458,597,609],"the":[24,45,52,96,143,170,184,190,198,225,231,234,242,354,436,450,469,497,505,556,562],"oral":[25],"dosage":[26],"form.":[27],"As":[28],"systemic":[29,55],"exposure":[30,56],"to":[31,36,49,57,92,173,229,313,325,378,423,441,476,602],"Bu":[32,59,141,425],"correlated":[35],"both":[37],"efficacy":[38],"and":[39,77,109,132,152,159,195,205,216,257,261,264,280,285,336,375,391,456,465,468,482,532],"toxicity,":[40],"we":[41],"used":[42,594],"area":[43],"under":[44],"concentration-time":[46],"curve":[47],"(AUC)":[48],"prospectively":[50],"determine":[51],"maximally":[53,97,563],"tolerated":[54,98,564],"IV":[58,140,424,591],"when":[60],"given":[61],"daily":[62,177,349],"combination":[64,596],"fludarabine":[66,598],"as":[67,218,536,599],"HCT":[68],"conditioning.":[69],"Three":[70],"AUC":[71,145,178,194,203,208,243,277,293,301,350,565,573],"levels":[72,507],"were":[73,163,187,247,265,289,370,419,446,454],"planned:":[74],"6000,":[75],"7500,":[76],"9000":[78,302],"micromole*min/L,":[79],"cohorts":[81,186,355,498],"of":[82,139,179,233,253,272,330,353,414,471,491,511,574,612],"20":[83,239,273,287],"patients":[84,608],"(pts)":[85],"each,":[86],"an":[88,114,175,276,572],"additional":[89,319],"10":[90],"pts":[91,103,240,274,288,299,306,321,416,557],"be":[93,101,105,477],"enrolled":[94,291],"at":[95,400,427,520,540],"AUC.":[99],"To":[100],"included,":[102],"had":[104,307],"16\u201365":[106],"years":[107],"old":[108],"have":[110,322],"a":[111,250,269,610],"hematologic":[112,613],"malignancy,":[113],"HLA":[115],"A,":[116],"B,":[117],"C,":[118],"DRB1":[119],"8/8":[120],"or":[121,125,342,443,514],"7/8":[122],"matched":[123],"related":[124],"unrelated":[126,440],"donor,":[127],"Karnofsky":[128],"performance":[129],"status":[130],"70\u2013100%,":[131],"adequate":[133],"organ":[134],"function.":[135],"The":[136,237,344,396,488],"initial":[137],"dose":[138,172,196,211,228,235,308,429,451,506],"for":[142,183,202,207,340,351],"first":[144,171,238,437],"level":[146,315,452],"was":[147,222,316,402,494,501,523,537,593],"170mg/m2/day":[148],"day":[150,153,157,160,226],"-6":[151],"-5":[154],"then,":[155],"-4":[158,215],"-3":[161,217,227],"doses":[162,182],"adjusted":[164],"pharmacokinetic":[167],"modeling":[168],"after":[169,224],"achieve":[174],"average":[176,348],"6000.":[180],"First":[181],"subsequent":[185],"linear":[191],"correlation":[192],"between":[193,449,504],"previous":[199],"cohort:":[200],"180mg/m2/day":[201],"7500":[204,294,559],"220mg/m2/day":[206],"9000,":[209],"adjustment":[212],"days":[214,334,394,439],"described.":[219],"Pharmacokinetic":[220],"analysis":[221],"verify":[230],"accuracy":[232],"adjustments.":[236],"6000":[244,278,575],"cohort":[245,271],"(DL1)":[246],"coenrolled":[248],"onto":[249,292],"randomized":[251],"trial":[252],"GVHD":[254,281,493],"prophylaxis":[255,282],"(tacrolimus":[256],"methotrexate":[258],"vs":[259],"tacrolimus":[260,284],"mycophenolate":[262],"mofetil)":[263],"analyzed":[266],"separately":[267],"from":[268],"second":[270],"receiving":[275],"(DL1A)":[279],"methotrexate.":[286],"then":[290],"(DL2),":[295],"followed":[296],"by":[297],"3":[298,411],"(DL3).":[303],"All":[304],"DL3":[305,366,392,401,483,533,549],"limiting":[309],"toxicity":[310,341,398,461],"so":[311],"accrual":[312],"that":[314,445,554],"stopped.":[317],"An":[318],"9":[320],"treated":[324],"date":[326],"DL2":[328,363,388,464,481,530,547],"(5":[329],"these":[331,415],"are":[332,337],"<100":[333],"posttransplant":[335],"not":[338,485,577],"evaluable":[339],"GVHD).":[343],"median":[345,376],"(and":[346],"range)":[347],"each":[352],"were:":[356,381],"DL1":[357,382,526,543],"5955":[358],"(5375-6557);":[359],"DL1A":[360,385,528,545],"6145":[361],"(4846-7018);":[362],"7555":[364],"(5920-8682);":[365],"8899":[367],"(8784-8955).":[368],"There":[369,418,500],"no":[371,420,502],"primary":[372],"engraftment":[373,380],"failures":[374],"times":[377],"neutrophil":[379],"15":[383],"days,":[384,387,390],"16":[386],"14":[389],"12":[393],"(p=0.01).":[395],"dose-limiting":[397],"seen":[399,426,462],"hepatic":[403],"venoocclusive":[404],"disease":[405],"(VOD)":[406],"which":[407],"developed":[408],"all":[410],"pts;":[412],"two":[413],"died.":[417],"seizures":[421],"attributable":[422],"any":[428,579],"level.":[430],"NCI":[431],"CTCAE":[432],"toxicities":[433],"(observed":[434],"100":[438],"infection":[442],"GVHD)":[444],"significantly":[447,486,524],"different":[448],"groups":[453],"dermatitis":[455],"VOD":[457],"more":[459,478],"severe":[460],"DL3.":[466],"Diarrhea":[467],"use":[470],"total":[472],"parenteral":[473],"nutrition":[474],"appeared":[475],"common":[479],"but":[484,570],"so.":[487],"cumulative":[489,509],"incidence":[490,510],"acute":[492],"similar":[495],"across":[496],"(p=0.11).":[499],"difference":[503],"relapse":[512],"(p=0.54)":[513],"event-free":[515],"survival":[516,539,580],"(p=0.4).":[517],"Nonrelapse":[518],"mortality":[519],"6":[521,541],"months":[522],"different:":[525],"20%,":[527],"0%,":[529],"17.5%":[531],"67%":[534],"(p=0.008)":[535],"overall":[538],"months:":[542],"75%,":[544],"90%,":[546],"80%,":[548],"33%":[550],"(p=0.04).":[551],"We":[552],"conclude":[553],"studied,":[558],"micromole*min/L":[560],"is":[561],"protocol-defined":[568],"criteria":[569],"exceeding":[571],"may":[576],"provide":[578],"benefit.":[581],"Disclosures:":[582],"Perkins:":[583],"PDL":[584],"BioPharma:":[585,616],"Research":[586,617],"Funding.":[587,618],"Off":[588],"Label":[589],"Use:":[590],"prior":[601],"allogeneic":[603],"variety":[611],"malignancies.":[614],"Field:PDL":[615]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2017-01-06T00:00:00"}